Chemotherapy of advanced gastric cancer with 72-hour continuous intravenous 5-fluorouracil infusion at 2-week intervals
Twenty-nine patients with advanced gastric adenocarcinoma were treated with 72-hour continuous intravenous infusion of 5-fluorouracil (30 mg/kg/24 hr) at 2-week intervals. Six patients (21%) achieved partial response and four (14%) had stabilization of their disease. The median duration of partial r...
Saved in:
Published in: | Medical and pediatric oncology Vol. 11; no. 5; p. 358 |
---|---|
Main Authors: | , |
Format: | Journal Article |
Language: | English |
Published: |
United States
1983
|
Subjects: | |
Online Access: | Get more information |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Twenty-nine patients with advanced gastric adenocarcinoma were treated with 72-hour continuous intravenous infusion of 5-fluorouracil (30 mg/kg/24 hr) at 2-week intervals. Six patients (21%) achieved partial response and four (14%) had stabilization of their disease. The median duration of partial response was 8 months, with a range of 5-19 months. The median survival time for all patients from the start of chemotherapy was 8 months. Various prognostic factors important in determining response and survival are analyzed. |
---|---|
AbstractList | Twenty-nine patients with advanced gastric adenocarcinoma were treated with 72-hour continuous intravenous infusion of 5-fluorouracil (30 mg/kg/24 hr) at 2-week intervals. Six patients (21%) achieved partial response and four (14%) had stabilization of their disease. The median duration of partial response was 8 months, with a range of 5-19 months. The median survival time for all patients from the start of chemotherapy was 8 months. Various prognostic factors important in determining response and survival are analyzed. |
Author | MacDonald, W C Shah, A |
Author_xml | – sequence: 1 givenname: A surname: Shah fullname: Shah, A – sequence: 2 givenname: W C surname: MacDonald fullname: MacDonald, W C |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/6633428$$D View this record in MEDLINE/PubMed |
BookMark | eNotkDtPwzAAhD0UlbawsiH5D7j4GccjioAiVWKBuXL8IIbEjpykVf89qej03elON9waLGKKDoAHgrcEY_rU9WlLlcCEYEHYAqwwViUigtFbsB6GHzx7JcslWBYFY5yWK3CqGtelsXFZ92eYPNT2qKNxFn7rYczBQHOxGZ7C2EBJUZOmDE2KY4hTmgYY4pj10cWLFsi3U8pzQ5vQzpGfhpAi1COk6OTc76Xt8lG3wx248TPc_ZUb8PX68lnt0P7j7b163iPDsWRIcuk99VgJ7oUosNdaKCs8UbXglpWsUMY4zVVJKZfGmlJY6WrqiJe1NopuwOP_bj_VnbOHPodO5_PhegD9AxpOX64 |
CitedBy_id | crossref_primary_10_1093_oxfordjournals_annonc_a057858 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1002/mpo.2950110513 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 6633428 |
Genre | Journal Article |
GroupedDBID | .GA .GJ .Y3 10A 1L6 1OB 1OC 1ZS 31~ 3WU 4ZD 51W 51X 52N 52O 52P 52R 52S 52T 52W 52X 53G 5GY 66C 7PT 8-1 8-4 8-5 930 A01 A03 AAEVG AAHHS AANLZ AAXRX AAZKR ABCUV ABIJN ABJNI ABPPZ ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACMXC ACPOU ACXBN ACXQS ADBTR ADEOM ADIZJ ADMGS ADOZA AEEZP AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AIACR AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZFZN BDRZF BRXPI BY8 CGR CO8 CS3 CUY CVF D-7 D-F DCZOG DRFUL DRMAN DRSTM EBS ECM EIF EJD F00 F01 F04 F5P FEDTE G-S GLUZI GODZA HBH HGLYW HHY HHZ HVGLF JPC KQQ LATKE LAW LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LYRES M6P MEWTI MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM NPM P4B P4D PALCI QB0 QRW RIWAO ROL RWI SAMSI SUPJJ UB1 W99 WIB WIH WIJ WIK WJL WQJ WRC WUP WWO WXI WXSBR XG1 XPP XV2 ZGI ZXP |
ID | FETCH-LOGICAL-c4073-747ff2f0954f5560faa59d5f19b54d38369ccea4982247cdc85d7eb2e1f7bac92 |
ISSN | 0098-1532 |
IngestDate | Sat Sep 28 08:40:34 EDT 2024 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 5 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4073-747ff2f0954f5560faa59d5f19b54d38369ccea4982247cdc85d7eb2e1f7bac92 |
PMID | 6633428 |
ParticipantIDs | pubmed_primary_6633428 |
PublicationCentury | 1900 |
PublicationDate | 1983-00-00 |
PublicationDateYYYYMMDD | 1983-01-01 |
PublicationDate_xml | – year: 1983 text: 1983-00-00 |
PublicationDecade | 1980 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Medical and pediatric oncology |
PublicationTitleAlternate | Med Pediatr Oncol |
PublicationYear | 1983 |
SSID | ssj0009978 |
Score | 1.1939124 |
Snippet | Twenty-nine patients with advanced gastric adenocarcinoma were treated with 72-hour continuous intravenous infusion of 5-fluorouracil (30 mg/kg/24 hr) at... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 358 |
SubjectTerms | Adenocarcinoma - diagnosis Adenocarcinoma - drug therapy Adenocarcinoma - mortality Adult Aged Drug Administration Schedule Female Fluorouracil - administration & dosage Humans Infusions, Parenteral Male Middle Aged Stomach Neoplasms - diagnosis Stomach Neoplasms - drug therapy Stomach Neoplasms - mortality |
Title | Chemotherapy of advanced gastric cancer with 72-hour continuous intravenous 5-fluorouracil infusion at 2-week intervals |
URI | https://www.ncbi.nlm.nih.gov/pubmed/6633428 |
Volume | 11 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NT9swFLfaTZu4TOwDAWOTD7shb40_SHycSicu5QIT3JA_abU1qVpKxX_Pc-zQhGkaO3CJIjuy4vx-ennv-flnhL4YwzjnihE20JzwXHuiKBOEaz3gKrPSm_oQ27P89LI4HvFRr9ekBjZtz4o0tAHWYefsf6D9MCg0wD1gDldAHa5Pwj0oAKRdVXedRf5rFY7oMKHMy7hFTMDmlExg0LpgfVquQjnsNGR7b6NyqyD-96pawBPKTIM4h18t6_Llm0NK1s79qtUmFvD6y7aT2yz-1BoEzVEgh1VpOin8s4madJKpY9XKVF-k9K2NO_QK1kpIJCMrITAVrGtksxaZRMtisqjc_oclj8qws3n1lUoRnBQR96y2IJzPagzBZ2KcFv_sfKSrnXr6qA9OUvCjh-ONWrNMv_A0k0btc0C_dd9oC71K4zwKS2r35HwbvUlxBf4eCfEW9Vz5Dr0ep8qJ92jd5gWuPG54gRMvcOQFDrzAiRd4wwvc4gXu8gI3vMDqBkde4AdefEA_f4zOhyckHbpBDMT2jEB46T314HlzL8Ad9koJaYXPpBbcsoIdSWOc4kH3kefGmkLY3GnqMp9rZSTdQS_KqnS7COfOCke9zDQYhIHMVVFwaTlThc5gRL-HduInu5pHZZWr9C33_9bxEW1tGHeAXnqYh_uE-ku7-lwjeA8pDmVM |
link.rule.ids | 782 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chemotherapy+of+advanced+gastric+cancer+with+72-hour+continuous+intravenous+5-fluorouracil+infusion+at+2-week+intervals&rft.jtitle=Medical+and+pediatric+oncology&rft.au=Shah%2C+A&rft.au=MacDonald%2C+W+C&rft.date=1983-01-01&rft.issn=0098-1532&rft.volume=11&rft.issue=5&rft.spage=358&rft_id=info:doi/10.1002%2Fmpo.2950110513&rft_id=info%3Apmid%2F6633428&rft_id=info%3Apmid%2F6633428&rft.externalDocID=6633428 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0098-1532&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0098-1532&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0098-1532&client=summon |